Time to first cigarette, a proxy of nicotine dependence, increases the risk of pulmonary impairment, independently of current and lifetime smoking behavior

Nicotine and Tobacco Research

Volumn 18, Issue 6, 2016, Pages 1431-1439

  Selya, Arielle S ^a   Oancea, Sanda Cristina ^a   Thapa, Sunita ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COUGHING; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DUST; ENVIRONMENTAL EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUME; HUMAN; MALE; OCCUPATIONAL EXPOSURE; PHLEGM; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK FACTOR; SELF REPORT; SMOKING; SPIROMETRY; SYMPTOM; TIME TO FIRST CIGARETTE; TOBACCO DEPENDENCE; WHEEZING; MIDDLE AGED; RISK ASSESSMENT; TIME FACTOR;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; SMOKING; TIME FACTORS; TOBACCO USE DISORDER;

EID: 84973138922     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv291     Document Type: Article

References (42)

1. USDDH. The Health Consequences of Smoking - 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health & Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014:1-1081
2. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4): 347-365. doi:10.1164/rccm.201204-0596PP.
3. Kandel DB, Chen K. Extent of smoking and nicotine dependence in the United States: 1991-1993. Nicotine Tob Res. 2000;2(3): 263-274. doi:10.1080/14622200050147538.
4. DiFranza JR, Savageau JA, Fletcher K, et al. Measuring the loss of autonomy over nicotine use in adolescents: the DANDY (Development and Assessment of Nicotine Dependence in Youths) study. Arch Pediatr Adolesc Med. 2002;156(4): 397-403. doi:10.1001/archpedi.156.4.397.
5. American Psyciatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
6. Fagerström K. Time to first cigarette; the best single indicator of tobacco dependence? Monaldi Arch Chest Dis. 2003;59(1):91-94.
7. Ito H, Gallus S, Hosono S, et al. Time to first cigarette and lung cancer risk in Japan. Ann Oncol. 2013;24(11): 2870-2875. doi:10.1093/annonc/mdt362.
8. Kunze U, Scholer E, Schoberberger R, et al. Lung cancer risk measured by the Fagerstrom Test for Nicotine Dependence? Nicotine Tob Res. 2007;9(5):625-626. doi:10.1080/14622200601096998.
9. Muscat JE, Ahn K, Richie JP, Stellman SD. Nicotine dependence phenotype and lung cancer risk. Cancer. 2011;117(23): 5370-5376. doi:10.1002/cncr.26236.
10. Gu F, Wacholder S, Kovalchik S, et al. Time to smoke first morning cigarette and lung cancer in a case-control study. J Natl Cancer Inst. 2014;106(6): 1-8. doi:10.1093/jnci/dju118.
11. Muscat JE, Liu H-P, Livelsberger C, Richie JP Jr, Stellman SD. The nicotine dependence phenotype, time to first cigarette, and larynx cancer risk. Cancer Causes Control. 2012;23(3): 497-503. doi:10.1007/s10552-012-9909-x.
12. Muscat JE, Ahn K, Richie JP, Stellman SD. Nicotine dependence phenotype, time to first cigarette, and risk of head and neck cancer. Cancer. 2011;117(23): 5377-5382. doi:10.1002/cncr.26235.
13. Vozoris NT, Stanbrook MB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med. 2011;105(3): 477-484. doi:10.1016/j.rmed.2010.08.011.
14. Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61(12): 1043-1047. doi:10.1136/thx.2006.064410.
15. Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence Phenotype Workgroup; Baker TB, Piper ME, McCarthy DE, et al. Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res. 2007;9(suppl 4):S555-570. doi:10.1080/14622200701673480.
16. Johnson CL, Paulose-Ram R, Ogden CL, et al. National Health and Nutrition Examination Survey: Analytic Guidelines, 1999-2010. Hyattsville, MD: National Center for Health Statistics; 2013.
17. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of Spirometry. Eur Respir J. 2006;26(2): 319-338. doi:10.1183/09031936.05.00034805.
18. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179-187. doi:10.1164/ajrccm.159.1.9712108.
19. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD. Global Initative for Chronic Obstructive Lung Disease (GOLD); Global Initative for Chronic Obstructive Lung Disease (GOLD); 2014;1-102. http://www.goldcopd.org/.
20. Peto J. That the effects of smoking should be measured in pack-years: misconceptions 4. Br J Cancer. 2012;107(3): 406-407. doi:10.1038/bjc.2012.97.
21. Hatcher L. A Step-By-Step Approach to Using the SAS System for Factor Analysis and Structural Equation Modeling. Cary, NC: SAS Institute; 1994.
22. Lumley T. Complex Surveys: A Guide to Analysis Using R. Hoboken, NJ: John Wiley & Sons, Inc.; 2010.
23. Hammond D, Fong GT, Cummings KM, Hyland A. Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiol Biomarkers Prev. 2005;14(6): 1370-1375. doi:10.1158/1055-9965.EPI-04-0498.
24. Scherer G. Smoking behaviour and compensation: a review of the literature. Psychopharmacology. 1999;145(1): 1-20.
25. Strasser AA, Lerman C, Sanborn PM, Pickworth WB, Feldman EA. New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Drug Alcohol Depend. 2007;86(2-3): 294-300.
26. Woodward M, Tunstall-Pedoe H. Self-titration of nicotine: evidence from the Scottish Heart Health Study. Addiction. 1993;88(6): 821-830.
27. Mustonen TK, Spencer SM, Hoskinson RA, Sachs DP, Garvey AJ. The influence of gender, race, and menthol content on tobacco exposure measures. Nicotine Tob Res. 2005;7(4): 581-590. doi:10.1080/14622200500185199.
28. Reitzel LR, Li Y, Stewart DW, et al. Race moderates the effect of menthol cigarette use on short-term smoking abstinence. Nicotine Tob Res. 2013;15(5): 883-889. doi:10.1093/ntr/nts335.
29. Bohadana A, Nilsson F, Rasmussen T, Martinet Y. Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior. Nicotine Tob Res. 2003;5(1): 111-116. doi:10.1080/1462220021000060482.
30. Todd M. Daily processes in stress and smoking: effects of negative events, nicotine dependence, and gender. Psychol Addict Behav. 2004;18(1): 31-39. doi:10.1037/0893-164x.18.1.31.
31. Jiménez-Ruiz CA, Miravitlles M, Sobradillo V, et al. Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease? Nicotine Tob Res. 2004;6(4):649-653. doi:10.1080/1462220041000172 7948.
32. Kim DK, Hersh CP, Washko GR, et al. Epidemiology, radiology, and genetics of nicotine dependence in COPD. Respir Res. 2011;12: 1-11. doi:10.1186/1465-9921-12-9.
33. Macqueen DA, Heckman BW, Blank MD, et al. Variation in the alpha 5 nicotinic acetylcholine receptor subunit gene predicts cigarette smoking intensity as a function of nicotine content. Pharmacogenomics J. 2014;14(1): 70-76. doi:10.1038/tpj.2012.50.
34. Strasser AA, Benowitz NL, Pinto AG, et al. Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level. Cancer Epidemiol Biomarkers Prev. 2011;20(2): 234-238. doi:10.1158/1055-9965.epi-10-0674.
35. Strasser AA, Malaiyandi V, Hoffmann E, Tyndale RF, Lerman C. An association of CYP2A6 genotype and smoking topography. Nicotine Tob Res. 2007;9(4): 511-518. doi:10.1080/14622200701239605.
36. Pillai SG, Ge D, Zhu G, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 2009;5(3):e1000421. doi:10.1371/journal. pgen.1000421.
37. Siedlinski M, Tingley D, Lipman PJ, et al. Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. Hum Genet. 2013;132(4): 431-441. doi:10.1007/s00439-012-1262-3.
38. VanderWeele TJ, Asomaning K, Tchetgen Tchetgen EJ, et al. Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am J Epidemiol. 2012;175(10):1013-1020. doi:10.1093/aje/kwr467.
39. O'Loughlin J, Paradis G, Kim W, et al. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. Tob Control. 2004;13(4): 422-428. doi:10.1136/tc.2003.007070.
40. Cho MH, Castaldi PJ, Wan ES, et al. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet. 2012;21(4): 947-957. doi:10.1093/hmg/ddr524.
41. Goodwin RD, Lavoie KL, Lemeshow AR, Jenkins E, Brown ES, Fedoronko DA. Depression, anxiety, and COPD: the unexamined role of nicotine dependence. Nicotine Tob Res. 2012;14(2): 176-183. doi:10.1093/ntr/ntr165.
42. Guertin KA, Gu F, Wacholder S, et al. Time to first morning cigarette and risk of chronic obstructive pulmonary disease: smokers in the PLCO cancer screening trial. PLoS One. 2015;10(5):e0125973. doi:10.1371/journal.pone.0125973.